本页面由Tiger Trade Technology Pte. Ltd.提供服务

Oric Pharmaceuticals Inc.

12.03
+0.02000.17%
盘后:12.030.00000.00%19:30 EDT
成交量:269.55万
成交额:3,145.73万
市值:12.45亿
市盈率:-8.90
高:12.20
开:11.87
低:10.93
收:12.01
52周最高:14.68
52周最低:7.23
股本:1.04亿
流通股本:8,868.67万
量比:1.85
换手率:3.04%
股息:- -
股息率:- -
每股收益(TTM):-1.3513
每股收益(LYR):-1.4747
净资产收益率:-39.80%
总资产收益率:-25.97%
市净率:3.27
市盈率(LYR):-8.16

数据加载中...

2026/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/07/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/23

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/04

重要事件披露

Form 8-K - Current report
2026/04/01

重要事件披露

Form 8-K - Current report
2026/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/24

重要事件披露

Form 8-K - Current report